Skip to playerSkip to main content
  • 6 years ago
Deepak Malik, pharma analyst at Edelweiss Securities spoke at length about Sun Pharma as well as his latest report which focuses on the opportunity of the diabetes segment in the domestic market.
Be the first to comment
Add your comment

Recommended